Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA supports Vical's Allovectin-7 clinical development program

April 5, 2001

Clinical data reported for an optimized Theratope vaccine formulation

April 5, 2001

Renewed focus on oncology products at Transgene

April 5, 2001

MabCampath recommended for approval in the E.U.

April 4, 2001

Timing of M-Vax administration crucial for survival and immunological outcomes

April 3, 2001

AACR news: preliminary phase I/II results with Vaxid indicate good safety, immunogenicity

March 30, 2001

Tumor growth completely suppressed by natural biological response modifier

March 28, 2001

AACR news: ImClone designs novel protein-based melanoma vaccine

March 28, 2001

FDA places M-Vax and O-Vax on clinical hold

March 28, 2001

Multiple-cytokine fusion proteins prepared at Lexigen for use in cancer

March 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...